Shah K - Search Results

1

PET imaging of glioblastoma multiforme EGFR expression for therapeutic decision guidance.

Wehrenberg-Klee E, Redjal N, Leece A, Turker NS, Heidari P, Shah K, Mahmood U. Wehrenberg-Klee E, et al. Among authors: shah k. Am J Nucl Med Mol Imaging. 2015 Jun 15;5(4):379-89. eCollection 2015. Am J Nucl Med Mol Imaging. 2015. PMID: 26269775 Free PMC article.

2

Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo.

Arwert E, Hingtgen S, Figueiredo JL, Bergquist H, Mahmood U, Weissleder R, Shah K. Arwert E, et al. Among authors: shah k. Cancer Res. 2007 Aug 1;67(15):7335-42. doi: 10.1158/0008-5472.CAN-07-0077. Cancer Res. 2007. PMID: 17671203

3

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.

Martinez-Quintanilla J, Bhere D, Heidari P, He D, Mahmood U, Shah K. Martinez-Quintanilla J, et al. Among authors: shah k. Stem Cells. 2013 Aug;31(8):1706-14. doi: 10.1002/stem.1355. Stem Cells. 2013. PMID: 23389839 Free PMC article.

4

Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.

Duebgen M, Martinez-Quintanilla J, Tamura K, Hingtgen S, Redjal N, Wakimoto H, Shah K. Duebgen M, et al. Among authors: shah k. J Natl Cancer Inst. 2014 May 16;106(6):dju090. doi: 10.1093/jnci/dju090. Print 2014 Jun. J Natl Cancer Inst. 2014. PMID: 24838834

5

Molecular imaging with bioluminescence and PET reveals viral oncolysis kinetics and tumor viability.

Kuruppu D, Brownell AL, Shah K, Mahmood U, Tanabe KK. Kuruppu D, et al. Among authors: shah k. Cancer Res. 2014 Aug 1;74(15):4111-21. doi: 10.1158/0008-5472.CAN-13-3472. Epub 2014 May 29. Cancer Res. 2014. PMID: 24876106 Free PMC article.

6

Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.

Redjal N, Zhu Y, Shah K. Redjal N, et al. Among authors: shah k. Stem Cells. 2015 Jan;33(1):101-10. doi: 10.1002/stem.1834. Stem Cells. 2015. PMID: 25186100 Free PMC article.

7

Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions.

Heidari P, Kunawudhi A, Martinez-Quintanilla J, Szretter A, Shah K, Mahmood U. Heidari P, et al. Among authors: shah k. Theranostics. 2018 May 23;8(12):3380-3391. doi: 10.7150/thno.24017. eCollection 2018. Theranostics. 2018. PMID: 29930736 Free PMC article.

8

Pre-clinical tumor models of primary brain tumors: Challenges and opportunities.

Akter F, Simon B, de Boer NL, Redjal N, Wakimoto H, Shah K. Akter F, et al. Among authors: shah k. Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188458. doi: 10.1016/j.bbcan.2020.188458. Epub 2020 Oct 23. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33148506 Free PMC article. Review.

9

Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases.

Kuruppu D, Bhere D, Farrar CT, Shah K, Brownell AL, Mahmood U, Tanabe KK. Kuruppu D, et al. Among authors: shah k. Cancer Gene Ther. 2023 Jun;30(6):833-844. doi: 10.1038/s41417-023-00588-0. Epub 2023 Feb 1. Cancer Gene Ther. 2023. PMID: 36721067

10

Correction to: Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases.

Kuruppu D, Bhere D, Farrar CT, Shah K, Brownell AL, Mahmood U, Tanabe KK. Kuruppu D, et al. Among authors: shah k. Cancer Gene Ther. 2023 Jun;30(6):927. doi: 10.1038/s41417-023-00601-6. Cancer Gene Ther. 2023. PMID: 36890212 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,382 results

Search Page